Carl Holvey

September 20, 2022

Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry

Abstract Introduction: Cannabis-based medicinal products (CBMPs) have been identified as a promising novel therapeutic for symptoms and comorbidities related to…

October 5, 2021

Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis‐Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry

Abstract Cannabis‐based medicinal products (CBMPs) are an emerging therapeutic option in the management of primary chronic pain, using the role…

May 14, 2021

An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patients

Abstract Aim: Cannabis‐based medicinal products (CBMPs) are prescribed with increased frequency, despite a paucity of high‐quality randomized controlled trials. The…